Citace podle APA

Rondon, E., & Venkataraman, R. (2005). Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels. BioMed Central.

Styl Chicago

Rondon, Eliseo, a Ramesh Venkataraman. Afelimomab Led to a Modest Mortality Benefit in Patients With Severe Sepsis and Elevated Interleukin-6 Levels. BioMed Central, 2005.

Citace podle MLA

Rondon, Eliseo, a Ramesh Venkataraman. Afelimomab Led to a Modest Mortality Benefit in Patients With Severe Sepsis and Elevated Interleukin-6 Levels. BioMed Central, 2005.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..